Index of reports
> Cases with Febrile Neutropenia (16)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in female
Reported by a physician from Netherlands on 2012-07-30
Patient: female, weighing 61.5 kg (135.3 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 885 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
Epirubicin
Dosage: 177 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
Fluorouracil
Dosage: 885 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
NO Treatment Received
Dosage: no treatment received
Indication: Breast Cancer
Other drugs received by patient: Granisetron
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female, weighing 61.2 kg (134.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Cyclophosphamide
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Epirubicin
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Epirubicin
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Fluorouracil
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Fluorouracil
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Other drugs received by patient: Dexamethasone; Ondansetron
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female
Reactions: Diarrhoea, Chills, Febrile Neutropenia, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Epirubicin
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Fluorouracil
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Other drugs received by patient: Dexamethasone; Onsia
Possible Epirubicin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23
Patient: 48 year old female
Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-06
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-27
Possible Epirubicin side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 62 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Epirubicin
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Fluorouracil
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-20
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Cyclophosphamide
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Epirubicin
Dosage: (150 mg; every cycle), (150 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Epirubicin
Dosage: (150 mg; every cycle), (150 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Fluorouracil
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Fluorouracil
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Other drugs received by patient: Ondansetron; Lenograstim; Dexamethasone
Possible Epirubicin side effects in 63 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 63 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Epirubicin
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Fluorouracil
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Possible Epirubicin side effects in
Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-15
Patient:
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2 every three weeks intravenous not otherwise specified
Indication: Inflammatory Carcinoma of Breast Stage III
Epirubicin
Dosage: 100 mg/m2 every three weeks intravenous not other wise
Indication: Inflammatory Carcinoma of Breast Stage III
Fluorouracil
Dosage: 500 mg/m2 every three week (intravenously bolus)
Indication: Inflammatory Carcinoma of Breast Stage III
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient: female
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Trastuzumab
Indication: Breast Cancer
Trastuzumab
Possible Epirubicin side effects in 47 year old female
Reported by a physician from France on 2012-03-02
Patient: 47 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 940 mg, unk
Start date: 2010-07-22
Epirubicin
Dosage: 190 mg, unk
Start date: 2010-07-22
Fluorouracil
Dosage: 940 mg, unk
Start date: 2010-07-22
Panitumumab
Dosage: 690 mg, unk
Indication: Breast Cancer
Start date: 2010-07-22
Other drugs received by patient: Monazole; Solu-Medrol; Emend; Doxycycline; Medrol; Zofran
Possible Epirubicin side effects in female
Reported by a physician from Switzerland on 2012-03-02
Patient: female, weighing 41.0 kg (90.2 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 75mgm2 cyclic
Indication: Neoplasm
Start date: 2010-04-27
Votrient
Dosage: 400mg per day
Administration route: Oral
Indication: Neoplasm
Start date: 2010-04-28
Other drugs received by patient: Dexamethasone; Dexamethasone
Possible Epirubicin side effects in 47 year old female
Reported by a physician from France on 2012-02-29
Patient: 47 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 940 mg, unk
Start date: 2010-07-22
Epirubicin
Dosage: 190 mg, unk
Start date: 2010-07-22
Fluorouracil
Dosage: 940 mg, unk
Start date: 2010-07-22
Panitumumab
Dosage: 690 mg, unk
Indication: Breast Cancer
Start date: 2010-07-22
Other drugs received by patient: Zofran; Emend; Solu-Medrol; Monazole; Doxycycline; Medrol
Possible Epirubicin side effects in 47 year old female
Reported by a physician from France on 2012-02-28
Patient: 47 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 940 mg, unk
Start date: 2010-07-22
Epirubicin
Dosage: 190 mg, unk
Start date: 2010-07-22
Fluorouracil
Dosage: 940 mg, unk
Start date: 2010-07-22
Panitumumab
Dosage: 690 mg, unk
Indication: Breast Cancer
Start date: 2010-07-22
Other drugs received by patient: Emend; Doxycycline; Solu-Medrol; Monazole; Medrol; Zofran
Possible Epirubicin side effects in female
Reported by a physician from Italy on 2011-11-04
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Febrile Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 656 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
Epirubicin
Dosage: 131.20 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
Fluorouracil
Dosage: 656 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Other drugs received by patient: Augmentin '125'
Possible Epirubicin side effects in female
Reported by a physician from Italy on 2011-10-12
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Febrile Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 656 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
Epirubicin
Dosage: 131.20 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
Fluorouracil
Dosage: 656 mg, unk
Indication: Breast Cancer
Start date: 2011-06-28
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Other drugs received by patient: Augmentin '125'
|